for all the ”in the news” section
Pleio’s Chief Pharmacy Officer Mark Gregory, RPh discusses how oral GLP-1 medication will impact the patient medication journey, highlighting how easier access may improve initiation but not necessarily adherence. He explores how fragmented support, knowledge gaps, and emotional barriers can undermine persistence, and why sustained outcomes will depend on coordinated guidance beyond the prescription.
Pleio CEO Michael Oleksiw examines why, despite decades of digital innovation and billions invested, medication adherence remains stuck at 50%. Drawing on analysis of more than 140,000 patient conversations, he explores how the “Underminers” shape patient behavior and why the future of pharma depends on combining AI-driven insight with human connection to create lasting adherence.
Pleio’s AI platform, OLLIE, analyzed over 140,000 patient interactions to identify the top drivers of non-adherence across seven dimensions, including emotion, knowledge, and skills.
On “The Tech Glow Up” live from HLTH 2025, Vital.io and Pleio share how AI can make healthcare more human—from translating medical jargon to uncovering emotional barriers that hinder adherence and patient trust.
Jen Butler, CCO at Pleio, highlights new research linking loneliness to poor adherence and explains why pharma must pair digital tools with empathetic, human-centered patient support to improve outcomes.
Pleio CCO Jen Butler contributes a guest column to the October/November edition of Drug Store News. Therapies and technologies have advanced, but the lived experience of patients has often grown more isolating. Butler reimagines support for specialty patients through empathy and human connection.
Discover key takeaways from HLTH 2025 including a video from Pleio CEO Michael Oleksiw. Learn how Pleio is using AI to uncover emotional barriers and empower people, not replace them, in creating a more human patient experience.
In an interview with Pharmaceutical Commerce, Jen Butler, CCO of Pleio, noted that while DTC drug models expand access, they often leave patients without the guidance and connection needed for safe, consistent use. She emphasized that true adherence requires pairing digital convenience with human conversation and clinical oversight.
Pleio CEO Michael Oleksiw appears on Planetary Health First, Mars Next to explore how tackling loneliness is key to better health outcomes. He reveals how Pleio’s human-first approach helps patients stay on therapy by addressing emotional barriers that technology alone can’t solve.
As part of Fierce Pharma Marketing’s Rising Stars series, Pleio Marketing Manager Madison Norman discusses why empathy should lead the way in health tech. She explores how balancing innovation with human understanding can drive more meaningful patient experiences.